{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T04:02:23Z","timestamp":1649217743829},"reference-count":10,"publisher":"Cambridge University Press (CUP)","issue":"1","license":[{"start":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T00:00:00Z","timestamp":1609977600000},"content-version":"unspecified","delay-in-days":6,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Laryngol. Otol."],"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec id=\"S0022215120002753_sec_a1\"><jats:title>Background<\/jats:title><jats:p>Since the start of the coronavirus disease 2019 pandemic, transnasal humidified rapid-insufflation ventilatory exchange (\u2018THRIVE\u2019) has been classified as a high-risk aerosol-generating procedure and is strongly discouraged, despite a lack of conclusive evidence on its safety.<\/jats:p><\/jats:sec><jats:sec id=\"S0022215120002753_sec_a2\" sec-type=\"methods\"><jats:title>Methods<\/jats:title><jats:p>This study aimed to investigate the safety of transnasal humidified rapid-insufflation ventilatory exchange usage and its impact on staff members. A prospective study was conducted on all transnasal humidified rapid-insufflation ventilatory exchange cases performed in our unit between March and July 2020.<\/jats:p><\/jats:sec><jats:sec id=\"S0022215120002753_sec_a3\" sec-type=\"results\"><jats:title>Results<\/jats:title><jats:p>During the study period, 18 patients with a variety of airway pathologies were successfully managed with transnasal humidified rapid-insufflation ventilatory exchange. For each case, 7\u201310 staff members were present. Appropriate personal protective equipment protocols were strictly implemented and adhered to. None of the staff involved reported symptoms or tested positive for coronavirus disease 2019, up to at least a month following their exposure to transnasal humidified rapid-insufflation ventilatory exchange.<\/jats:p><\/jats:sec><jats:sec id=\"S0022215120002753_sec_a4\" sec-type=\"conclusions\"><jats:title>Conclusion<\/jats:title><jats:p>With strictly correct personal protective equipment use, transnasal humidified rapid-insufflation ventilatory exchange can be safely employed for carefully selected patients in the current pandemic, without jeopardising the health and safety of the ENT and anaesthetic workforce.<\/jats:p><\/jats:sec>","DOI":"10.1017\/s0022215120002753","type":"journal-article","created":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T06:40:07Z","timestamp":1610001607000},"page":"86-87","source":"Crossref","is-referenced-by-count":1,"title":["Transnasal humidified rapid-insufflation ventilatory exchange (\u2018THRIVE\u2019) in the coronavirus disease 2019 pandemic"],"prefix":"10.1017","volume":"135","author":[{"given":"S Y","family":"Hey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Milligan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R M","family":"Adamson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I J","family":"Nixon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A F","family":"McNarry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2021,1,7]]},"reference":[{"key":"S0022215120002753_ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s12630-020-01591-x"},{"key":"S0022215120002753_ref2","doi-asserted-by":"publisher","DOI":"10.1097\/HN9.0000000000000026"},{"key":"S0022215120002753_ref1","unstructured":"1 ENT UK guidelines for changes in ENT during COVID-19 pandemic. In: https:\/\/www.entuk.org\/ent-uk-guidelines-changes-ent-during-covid-19-pandemic [28 August 2020]"},{"key":"S0022215120002753_ref4","unstructured":"4 COVID-19. In: https:\/\/www.entuk.org\/covid-19 [28 August 2020]"},{"key":"S0022215120002753_ref7","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0000000000003303"},{"key":"S0022215120002753_ref5","doi-asserted-by":"publisher","DOI":"10.1177\/0194599820919751"},{"key":"S0022215120002753_ref10","doi-asserted-by":"publisher","DOI":"10.1111\/coa.12921"},{"key":"S0022215120002753_ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30084-9"},{"key":"S0022215120002753_ref3","doi-asserted-by":"publisher","DOI":"10.1111\/anae.15054"},{"key":"S0022215120002753_ref9","article-title":"Airway management guidance for the endemic phase of COVID-19","author":"Cook","year":"2020","journal-title":"Anaesthesia"}],"container-title":["The Journal of Laryngology &amp; Otology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0022215120002753","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T07:34:52Z","timestamp":1623396892000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0022215120002753\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S0022215120002753"],"URL":"https:\/\/doi.org\/10.1017\/s0022215120002753","relation":{},"ISSN":["0022-2151","1748-5460"],"issn-type":[{"value":"0022-2151","type":"print"},{"value":"1748-5460","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1]]}}}